Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by E Fund Management Co. Ltd.

E Fund Management Co. Ltd. reduced its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,549 shares of the pharmacy operator’s stock after selling 714 shares during the period. E Fund Management Co. Ltd.’s holdings in Walgreens Boots Alliance were worth $223,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Highlander Capital Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at approximately $26,000. Venturi Wealth Management LLC lifted its holdings in Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 981 shares during the last quarter. EverSource Wealth Advisors LLC increased its holdings in shares of Walgreens Boots Alliance by 308.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 845 shares during the last quarter. Rocky Mountain Advisers LLC purchased a new position in shares of Walgreens Boots Alliance in the 4th quarter valued at about $30,000. Finally, Planned Solutions Inc. acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth about $34,000. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Walgreens Boots Alliance

In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average cost of $18.05 per share, for a total transaction of $54,150.00. Following the transaction, the director now directly owns 3,000 shares of the company’s stock, valued at approximately $54,150. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, Director Inderpal S. Bhandari acquired 3,000 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The stock was purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the transaction, the director now owns 3,000 shares in the company, valued at approximately $54,150. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Manmohan Mahajan bought 6,000 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the acquisition, the chief financial officer now owns 166,969 shares in the company, valued at approximately $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

WBA has been the topic of a number of recent analyst reports. Morgan Stanley dropped their target price on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a research report on Monday, April 1st. Raymond James reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, March 26th. TD Cowen reduced their target price on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a report on Wednesday, April 3rd. Deutsche Bank Aktiengesellschaft cut their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a “hold” rating on the stock in a research report on Wednesday, April 3rd. Finally, Bank of America dropped their price objective on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research note on Tuesday, March 26th. Four analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $24.36.

Walgreens Boots Alliance Trading Up 0.1 %

Shares of WBA opened at $17.26 on Friday. The firm’s 50-day moving average is $19.35 and its two-hundred day moving average is $21.50. Walgreens Boots Alliance, Inc. has a twelve month low of $17.13 and a twelve month high of $32.89. The company has a current ratio of 0.66, a quick ratio of 0.32 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $14.89 billion, a P/E ratio of -2.46, a PEG ratio of 1.10 and a beta of 0.80.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.38. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. Walgreens Boots Alliance’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the business posted $1.16 EPS. On average, research analysts predict that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be given a $0.25 dividend. The ex-dividend date of this dividend is Monday, May 20th. This represents a $1.00 annualized dividend and a dividend yield of 5.79%. Walgreens Boots Alliance’s dividend payout ratio is presently -14.29%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.